Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).

AZD9898 是一种口服活性白三烯-C4 合成酶（LTC4S，谷胱甘肽 S-转移酶 II）抑制剂，IC50 为 0.28 nM。 AZD9898 具有治疗哮喘的潜力。 AZD9898 减轻 GABA 结合和肝毒性信号。

Insulin Receptor (1142 - 1153), pTyr1150, Biotinylated